Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06309004 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Development of an Online ACT Intervention for Disorders of Gut-Brain Interaction

Study acronym: iACTforDGBI
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 15, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 1, 2024 to Aug 31, 2025v2 Show 7 more changesShow less
    • Start date changed from estimate of May 1, 2024 to Sep 23, 2024
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 30 to confirmed 15
    • Study sites: 0 to 1
    • Study completion date: Aug 31, 2024 to Sep 30, 2025
    • Eligibility criteria expanded, about 4 words
    • Collaborators expanded, about 5 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to develop and test the iACTforDGBI intervention in a sample of Swedish individuals with DGBI (Disorders of Gut-Brain Interaction). The first substudy of this project (Substudy 1) aims to answer the following question: How can the design of iACTforDGBI be tailored to meet the specific needs of individuals with DGBI and clinically meaningful symptoms of anxiety and depression? Participants (individuals with symptoms compatible with a DGBI and anxiety and/or depression, and healthcare professionals working with DGBI patients) will be asked to participate in online focus-group interviews and provide information on their views of a preliminary version of the iACTforDGBi intervention.
Trial Details
NCT Number NCT06309004
Lead Sponsor Örebro University, Sweden
Collaborators: Uppsala University, SahlgrenskaUniversityHospital, Göteborg University
Conditions
(from sponsor)		 Anxiety and Depression, Disorders of Gut-brain Interaction
Related terms Anxiety Disorders, Depression
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov